October 13, 2017 / 11:28 AM / 6 days ago

BRIEF-InflaRx updates on $55 mln financing

Oct 13 (Reuters) -

* InflaRx - $55 million series D financing and investment round co-led by Bain Capital Life Sciences, Cormorant Asset Management LLC, RA Capital Management

* InflaRx - Proceeds will be used to advance clinical phase IIb development of InflaRx’s lead drug candidate IFX-1​ Source text for Eikon:

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below